Inga Hoffmann
Impact in
- Biochemistry top 5%
- Lipid metabolism and biosynthesis
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis
Papers in
-
- Ovarian cancer diagnosis and treatment 7
-
- Eicosanoids and Hypertension Pharmacology 2
- Co-authors
- Ernst H. Oliw (11 shared papers)Fredrik Jernerén (7 shared papers)Ulrike Garscha (4 shared papers)Manfred Jung (4 shared papers)Martin Roatsch (3 shared papers)Wolfgang Sippl (3 shared papers)Mats Hámberg (4 shared papers)Martin Pippel (2 shared papers)
- Journals
- Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (4 papers)Journal of Lipid Research (3 papers)Archives of Biochemistry and Biophysics (3 papers)The Journal of Pathology (1 paper)MedChemComm (1 paper)
- Partner nations
- GermanySwedenUnited Kingdom
In The Last Decade
Inga Hoffmann
30 papers receiving 602 citations
Peers
Comparison fields: 5 of 68
- Biochemistry 72
- Pharmacology 126
- Inorganic Chemistry 109
- Biotechnology 41
- Molecular Biology 300
Countries citing papers authored by Inga Hoffmann
This map shows the geographic impact of Inga Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inga Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inga Hoffmann more than expected).
Fields of papers citing papers by Inga Hoffmann
This network shows the impact of papers produced by Inga Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inga Hoffmann. The network helps show where Inga Hoffmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Inga Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 93 | |
| 2 | 2022 | 64 | |
| 3 | 2010 | 35 | |
| 4 | 2010 | 34 | |
| 5 | 2013 | 32 | |
| 6 | 2019 | 29 | |
| 7 | 2013 | 28 | |
| 8 | 2011 | 27 | |
| 9 | 2021 | 27 | |
| 10 | 2010 | 26 | |
| 11 | 2010 | 23 | |
| 12 | 2014 | 21 | |
| 13 | 1976 | 19 | |
| 14 | 2016 | 18 | |
| 15 | 2013 | 16 | |
| 16 | 2014 | 16 | |
| 17 | 2016 | 16 | |
| 18 | 2012 | 13 | |
| 19 | 2015 | 11 | |
| 20 | 2022 | 10 |
About Inga Hoffmann
Inga Hoffmann is a scholar working on Reproductive Medicine, Biochemistry, Inorganic Chemistry, Pharmacology and Biotechnology, having authored 31 papers that have together received 609 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (7 papers), Microbial Natural Products and Biosynthesis (7 papers), Metal-Catalyzed Oxygenation Mechanisms (7 papers), Epigenetics and DNA Methylation (5 papers), Biochemical and biochemical processes (3 papers), Plant biochemistry and biosynthesis (3 papers), Cancer-related gene regulation (3 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). The work is most often cited by research in Biochemistry (72 citations), Pharmacology (126 citations), Inorganic Chemistry (109 citations), Biotechnology (41 citations) and Molecular Biology (300 citations). Inga Hoffmann has collaborated with scholars based in Germany, Sweden and United Kingdom. Frequent co-authors include Ernst H. Oliw, Fredrik Jernerén, Ulrike Garscha, Manfred Jung, Martin Roatsch, Wolfgang Sippl, Mats Hámberg, Martin Pippel, Luca Carlino and Martin Schmitt. Their work appears in journals such as Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, Journal of Lipid Research, Archives of Biochemistry and Biophysics, The Journal of Pathology and MedChemComm.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.